17.08 USD
↘ 3.02 (15.02%)AT CLOSE (03:59 PM EDT)
Faeth Therapeutics, Inc. Common Stock
FTHNASDAQ • USD
17.08
↗ 0.00 (0.00%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
17.08
↗ 0.00 (0.00%)
Market: CLOSED
Faeth Therapeutics, Inc. Common Stock (FTH) trades at $17.08 per share. Technical indicators currently signal "Strong Sell". Key drivers include negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, FTH appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 23, 2026.
Open?$20.00
High?$20.15
Low?$16.80
Prev. Close?$20.10
Volume?353.7K
Avg. Volume?424.6K
VWAP?$18.19
Rel. Volume?0.83x
Bid / Ask
Bid?$14.03 × 100
Ask?$17.59 × 200
Spread?$3.56
Midpoint?$15.81
Valuation & Ratios
Market Cap?441.4M
Shares Out?25.8M
Float?14.0M
Float %?54.1%
P/E Ratio?N/A
P/B Ratio?2.55
EPS?-$7.57
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
Employees
29
Market Cap
441.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-02-04
Address
701 TILLERY STREET #12 #1010
AUSTIN, TX 78702
Phone: 512-200-2982
AUSTIN, TX 78702
Phone: 512-200-2982
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?14.79%High
Short Interest?2.1M
Days to Cover?3.6
Free Float14.0M
Avg Daily Volume569.4K
Settlement Date2026-09-30
Financial Health
Current Ratio?19.69Strong
Quick Ratio?19.69Strong
Cash Ratio?2.81Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.55CHEAP▾
Peers100
S&P63
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-113.1%WEAK▾
S&P3
ROA?-103.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-33862000
Enterprise Value?$414.5M
Fundamentals ratios updated end of day